300347 泰格医药
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额578,7701,150,4381,357,5011,423,796998,675
投资活动产生之现金流量净额(5,723,117)(1,534,225)(2,789,366)(2,782,684)(2,367,430)
筹资活动产生之现金流量净额(272,002)(7,806)809,254(163,093)9,339,115
汇率变动对现金及现金等价物的影响(21,706)8,79326,934(59,565)(47,483)
现金及现金等价物净增加/(减少)(5,438,055)(382,800)(595,677)(1,581,546)7,922,877
期初现金及现金等价物余额7,399,9417,782,7418,378,4189,959,9632,037,086
期末现金及现金等价物余额1,961,8877,399,9417,782,7418,378,4189,959,963